Literature DB >> 7791610

Kinetics of slow and tight-binding inhibitors.

S E Szedlacsek1, R G Duggleby.   

Abstract

Mesh：

Substances：

Year:  1995        PMID： 7791610     DOI： 10.1016/0076-6879(95)49034-5

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN： 0076-6879            Impact factor:   1.600


× No keyword cloud information.
  20 in total

1.  Inactivation of NEIL2 DNA glycosylase by pyridoxal phosphate reveals a loop important for substrate binding.

Authors:  Inga R Grin; Robert A Rieger; Dmitry O Zharkov
Journal:  Biochem Biophys Res Commun       Date:  2010-02-20       Impact factor: 3.575

2.  Development of a new methodology for screening of human immunodeficiency virus type 1 microbicides based on real-time PCR quantification.

Authors:  Renato S Aguiar; Luciana J Costa; Helena S Pereira; Rodrigo M Brindeiro; Amilcar Tanuri
Journal:  Antimicrob Agents Chemother       Date:  2006-11-20       Impact factor: 5.191

3.  Lactoferrin inhibits Porphyromonas gingivalis proteinases and has sustained biofilm inhibitory activity.

Authors:  Stuart G Dashper; Yu Pan; Paul D Veith; Yu-Yen Chen; Elena C Y Toh; Sze Wei Liu; Keith J Cross; Eric C Reynolds
Journal:  Antimicrob Agents Chemother       Date:  2012-01-03       Impact factor: 5.191

4.  Rhodopsin kinase: two mAbs binding near the carboxyl terminus cause time-dependent inactivation.

Authors:  C Bruel; K Cha; L Niu; P J Reeves; H G Khorana
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-28       Impact factor: 11.205

5.  pH-dependent hysteretic behaviour of human myeloblastin (leucocyte proteinase 3).

Authors:  A Baici; S E Szedlacsek; H Früh; B A Michel
Journal:  Biochem J       Date:  1996-08-01       Impact factor: 3.857

6.  Chemical barriers to human immunodeficiency virus type 1 (HIV-1) infection: retrovirucidal activity of UC781, a thiocarboxanilide nonnucleoside inhibitor of HIV-1 reverse transcriptase.

Authors:  G Borkow; J Barnard; T M Nguyen; A Belmonte; M A Wainberg; M A Parniak
Journal:  J Virol       Date:  1997-04       Impact factor: 5.103

7.  Unique thrombin inhibition mechanism by anophelin, an anticoagulant from the malaria vector.

Authors:  Ana C Figueiredo; Daniele de Sanctis; Ricardo Gutiérrez-Gallego; Tatiana B Cereija; Sandra Macedo-Ribeiro; Pablo Fuentes-Prior; Pedro José Barbosa Pereira
Journal:  Proc Natl Acad Sci U S A       Date:  2012-12-05       Impact factor: 11.205

8.  Preclinical characteristics of the hepatitis C virus NS3/4A protease inhibitor ITMN-191 (R7227).

Authors:  Scott D Seiwert; Steven W Andrews; Yutong Jiang; Vladimir Serebryany; Hua Tan; Karl Kossen; P T Ravi Rajagopalan; Shawn Misialek; Sarah K Stevens; Antitsa Stoycheva; Jin Hong; Sharlene R Lim; Xiaoli Qin; Robert Rieger; Kevin R Condroski; Hailong Zhang; Mary Geck Do; Christine Lemieux; Gary P Hingorani; Dylan P Hartley; John A Josey; Lin Pan; Leonid Beigelman; Lawrence M Blatt
Journal:  Antimicrob Agents Chemother       Date:  2008-09-29       Impact factor: 5.191

9.  Time evolution of the quaternary structure of Escherichia coli aspartate transcarbamoylase upon reaction with the natural substrates and a slow, tight-binding inhibitor.

Authors:  Jay M West; Jiarong Xia; Hiro Tsuruta; Wenyue Guo; Elizabeth M O'Day; Evan R Kantrowitz
Journal:  J Mol Biol       Date:  2008-09-16       Impact factor: 5.469

10.  Covalent EGFR inhibitor analysis reveals importance of reversible interactions to potency and mechanisms of drug resistance.

Authors:  Phillip A Schwartz; Petr Kuzmic; James Solowiej; Simon Bergqvist; Ben Bolanos; Chau Almaden; Asako Nagata; Kevin Ryan; Junli Feng; Deepak Dalvie; John C Kath; Meirong Xu; Revati Wani; Brion William Murray
Journal:  Proc Natl Acad Sci U S A       Date:  2013-12-17       Impact factor: 11.205
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.